Natera Change in Accounts Receivable 2014-2025 | NTRA

Natera change in accounts receivable for the twelve months ending June 30, 2025 was $-0.064B, a 43.61% decline year-over-year.

  • Natera annual change in accounts receivable for 2024 was $-0.036B, a 5.82% increase from 2023.
  • Natera annual change in accounts receivable for 2023 was $-0.034B, a 72.28% decline from 2022.
  • Natera annual change in accounts receivable for 2022 was $-0.122B, a 181.12% increase from 2021.

Natera Change in Accounts Receivable 2014-2025 | NTRA

  • Natera annual change in accounts receivable for 2024 was $-0.036B, a 5.82% increase from 2023.
  • Natera annual change in accounts receivable for 2023 was $-0.034B, a 72.28% decline from 2022.
  • Natera annual change in accounts receivable for 2022 was $-0.122B, a 181.12% increase from 2021.
Related Stocks
Company NameMarket
Cap
Danaher (DHR)$151.7B
CVS Health (CVS)$90.4B
Elevance Health (ELV)$71.3B
Cencora (COR)$56.7B
DiDi Global (DIDIY)$27.6B
Labcorp Holdings (LH)$23.1B
BioMerieux (BMXMF)$17.5B
EUROFINS SCIENT (ERFSF)$15.7B
ICON (ICLR)$14.2B
Medpace Holdings (MEDP)$13B
CochLear (CHEOY)$12.8B
Solventum (SOLV)$12.8B
Viatris (VTRS)$12.4B
Caris Life Sciences,�Inc (CAI)$11.1B
Revvity (RVTY)$10.9B
Avantor (AVTR)$9B
Sonic Healthcare (SKHHY)$8B
Charles River Laboratories (CRL)$8B
HealthEquity (HQY)$7.8B
Bausch + Lomb (BLCO)$5.3B
Sotera Health (SHC)$4.7B
BrightSpring Health Services (BTSG)$4.4B
Amplifon S.p.A (AMFPF)$3.9B
KindlyMD (NAKA)$3.8B
GeneDx Holdings (WGS)$3.7B
Alignment Healthcare (ALHC)$3.1B
Concentras Parent (CON)$3B
Surgery Partners (SGRY)$3B
Organon (OGN)$2.5B
Premier (PINC)$2.1B